Bio-rad Laboratories, Inc. (BIO) Technical Analysis
$251.49▲0.34%
Market is closed - opens 7 PM, 07 Jul 2025
Insights
- Bio-rad Laboratories is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Bio-rad Laboratories stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Bio-rad Laboratories stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Bio-rad Laboratories stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.87 | Sell |
Stochastic | 89.82, 85.16 | Neutral |
Ultimate Oscillator | 58.92 | Neutral |
Stochastic Relative Strength Index | 100.0, 94.73 | Neutral |
Moving Average Convergence Divergence | 4.26, 1.91 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 243.01 | Buy |
20 | 235.43 | Sell |
50 | 236.48 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 243.59 | Buy |
20 | 239.1 | Sell |
50 | 240.06 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 239.08 | Buy |
20 | 233.53 | Buy |
50 | 235.04 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 249.79 | Buy |
20 | 243.91 | Buy |
50 | 229.26 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 251.96 | Buy |
20 | 249.43 | Buy |
50 | 239.06 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 258.57 |
Resistance L2 | 255.73 |
Resistance L1 | 253.19 |
Pivot Point | 250.36 |
Support L1 | 247.82 |
Support L2 | 244.99 |
Support L3 | 242.45 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.